LIT-001
id:
lit-001-168-13051270
title:
LIT-001
text:
LIT-001 is a small-molecule oxytocin receptor agonist and vasopressin receptor mixed agonist and antagonist that was first described in the literature in 2018. Along with TC OT 39 and WAY-267464, it is one of the first small-molecule oxytocin receptor agonists to have been developed. LIT-001 has greatly improved pharmacokinetic properties relative to oxytocin, reduces social deficits in animal models, and may have potential as a therapeutic agent in the treatment of social disorders like autism
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/LIT-001
date created:
2023-04-04T23:38:32Z
date modified:
2024-08-31T01:05:21Z
main entity:
{"identifier":"Q117447401","url":"https://www.wikidata.org/entity/Q117447401"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/7/79/LIT-001.svg","width":940,"height":445}
fields total:
13
integrity:
16